Biopharmreports

Biopharm Reports is a technical insight and market research consultancy, established in 2006 by John Bates. The company is focused on emerging technology and market developments, notably in Neurodegenerative Disease, Cancer, Pain and Stroke.

First | Previous | Next | Last

Report Name		Date	Price
	VEGF Inhibition: Therapy-Indicating and Prognostic Biomarkers, 2011	Oct 2011	$950
	Biomarkers in Alzheimers Disease, 2011	Apr 2011	£1490
	Alzheimers Disease: Autoantibodies, Vaccines and Therapeutic Antibodies Pipeline, 2011	Mar 2011	£1490
	Prostate Cancer Vaccines and Therapeutic Antibodies: Pipeline, 2011	Feb 2011	£1490
	Breast Cancer Vaccines and Therapeutic Antibodies: Pipeline, 2011	Feb 2011	£1490
	Alzheimers Disease Biomarkers in Cerebrospinal Fluid and Blood, 2011	Feb 2011	£1030
	Image-Based Biomarkers in Alzheimers Disease, 2011	Feb 2011	£550
	Lung Cancer Vaccines and Therapeutic Antibodies: Pipeline, Strategies and Clinical	Jan 2011	£1490
	Lung Cancer Vaccines: Pipeline, Strategies and Clinical	Jan 2011	£950
	Lung Cancer Vaccines: Pipeline, Strategies and Clinical	Jan 2011	£950
	Lung Cancer Therapeutic Antibodies: Pipeline, Strategies and Clinical	Jan 2011	£750
	Biomarkers in Parkinsons Disease, 2011	Jan 2011	£1490
	Biomarkers in Breast Cancer, 2011	Jan 2011	£1490
	Stroke: Competing Treatments and Market Entry Considerations	Jun 2010	£2490
	Neuropathic Pain: Competing Treatments and Market Entry Considerations	Jun 2010	£2490
	Hypertension: Competing Treatments and Market Entry Considerations	Jun 2010	£2490
	Alzheimers Disease: Competing Treatments and Market Entry Considerations	Jun 2010	£1490
	Targeting Cancer Stem Cells: Therapeutic Strategies, Pipeline, Biomarkers and Opportunities	Jan 2010	£1490
	Peripheral Neuropathy and Neuropathic Pain, 2008: Current, pipeline and emerging drugs for the treatment of peripheral neuropathy and neuropathic pain	Jun 2009	£1490
	Alzheimers Disease: Markets, Pipeline and Opportunities 2009	Apr 2009	£1490
	Cancer Drug Resistance	Jan 2009	£1490
	Antibiotics and Drug Resistance 2008	Mar 2008	£1490

Total reports : 22

PDF Format Reports will be
delivered by email within
12 to 24 hours after placing
the order (Mon-Fri IST)

Australia Research Reports
Brazil Research Reports
Asia Research Reports
China Research Reports
Canada Research Reports
Europe Research Reports
France Research Reports
Egypt Research Reports
Global Research Reports
Greece Research Reports
Germany Research Reports
Japan Research Reports
India Research Reports
Ireland Research Reports
Korea Research Reports
Mexico Research Reports
Maldives Research Reports
New Zealand Research Reports
Netherland Research Reports
Poland Research Reports
Russia Research Reports
South Africa Research Reports
Sri Lanka Research Reports
Singapore Research Reports
Switzerland Research Reports
UK Research Reports
USA Research Reports
UAE Research Reports
Uruguay Research Reports

ExxonMobil Company Analysis
Toyota Motors Company Analysis
ConocoPhillips Company Analysis
Sinopec Company Analysis
Total S.A. Company Analysis
Verizon Company Analysis
Gazprom Company Analysis
JPMorgan Company Analysis
Chevron Company Analysis
E.ON Company Analysis
PetroChina Company Analysis
Allianz Company Analysis
AXA Company Analysis
Carrefour Company Analysis
General Electric Company Analysis
Bank of America Company
Assicurazioni Generali Company
Samsung Electronics Company
GDF Suez Company Analysis
McKesson Corporation Company
Volkswagen Group Company
Royal Dutch Shell Company